Edesa Biotech Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 12
Employees
  • Stock Symbol
  • EDSA
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $7.70
  • (As of Friday Closing)

Edesa Biotech General Information

Description

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 100 Spy Court
  • Markham, Ontario L3R 5H6
  • Canada
+1 (289) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Edesa Biotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.70 $8.14 $4.05 - $12.00 $102M 13.3M 3.2M -$1.05

Edesa Biotech Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019 FY 2018 30-Sep-2018
EV 59,161 74,538 39,061 (3,874)
Revenue 1 329 411 212
EBITDA (11,557) (6,344) (2,829) (4,850)
Net Income (11,672) (6,364) (2,777) (5,039)
Total Assets 16,877 10,762 5,718 11,780
Total Debt 121 164 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Edesa Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edesa Biotech‘s full profile, request access.

Request a free trial

Edesa Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in expl
Drug Discovery
Markham, Canada
12 As of 2020
000.00
00000000 000.00

000000 0

im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis a
000000000000000
Cranford, NJ
00 As of 0000
000.00
000000000 000.00

0000000

ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
000000000000000
Wayne, PA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edesa Biotech Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Citius Pharma Formerly Angel backed Cranford, NJ 00 000.00 000000000 000.00
0000000 0000000000 Formerly VC-backed Wayne, PA 00 00000 00000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Edesa Biotech Executive Team (5)

Name Title Board Seat Contact Info
Par Nijhawan MD Founder, Chief Executive Officer, Secretary & Board Director
Michael Brooks Ph.D President
Gary Koppenjan Vice President, Investor Relations and Communications
Kathi Niffenegger Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
You’re viewing 4 of 5 executive team members. Get the full list »

Edesa Biotech Board Members (8)

Name Representing Role Since
Carlo Sistilli Edesa Biotech Board Member 000 0000
Frank Oakes Self Board Member 000 0000
Lorin Johnson Ph.D Self Board Member 000 0000
Par Nijhawan MD Edesa Biotech Founder, Chief Executive Officer, Secretary & Board Director 000 0000
Paul William Pay Edesa Biotech Board Director 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Edesa Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edesa Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Edesa Biotech‘s full profile, request access.

Request a free trial

Edesa Biotech Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 07-May-2019 000000000000000000 00.000 Biotechnology 000 00000000 00
To view Edesa Biotech’s complete acquisitions history, request access »